Trademark: 90980823
Status Date
Tuesday, April 2, 2024
Registration Number
7347499
Registration Date
Tuesday, April 2, 2024
Filing Date
Wednesday, February 17, 2021
Published for Opposition
Tuesday, December 7, 2021
9 Downloadable computer software for the collection, management, and analysis of data for use in the fields of scientific research, clinical research, scientific diagnostics, and medical diagnostics; downloadable computer software for analyzing biological samples; downloadable computer software for analyzing biological samples for medical purposes, namely, for the diagnosis and treatment of cancer; downloadable computer software for use with reagents and reagent kits, all for the purpose of detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, all in the fields of scientific research, clinical research, scientific diagnostics research, and medical diagnostics; downloadable computer software for bioinformatics and gene expression microarray image analysis, namely, gene expression quantification, gene image processing, and gene information processing; downloadable computer software for health and wellness assessment, namely, for use in genomic analysis; downloadable computer software for genetic and bioinformatics analysis
5 Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being for medical diagnostic purposes; biological and biochemical reagents and reagent kits for selectively amplifying nucleic acid fragments for medical diagnostic purposes; biological and biochemical kits comprised of diagnostic preparations for medical purposes, namely, for the diagnosis and treatment of cancer; biological and biochemical kits for medical diagnostic purposes
1 Reagents and reagent kits comprising nucleic acids, naturally occurring and modified nucleotides, enzymes, and buffers, all for the purpose of preparing, detecting, sequencing, and analyzing nucleic acids and other biological molecules, samples of biological molecules, genes, genomes, nucleotide sequence variants and modifications, regulations, transcriptions, and expressions, with the aforementioned reagents and reagent kits being in the fields of scientific research, clinical research, and scientific diagnostics research; biological and biochemical reagents and reagent kits for selectively amplifying nucleic acid fragments for scientific research, clinical research, and scientific diagnostics research; biological and biochemical kits for scientific research, clinical research, and scientific diagnostics research
Apr 2, 2024
Notice Of Registration Confirmation Emailed
Apr 2, 2024
Registered-Principal Register
Feb 24, 2024
Notice Of Acceptance Of Statement Of Use E-Mailed
Feb 23, 2024
Allowed Principal Register - Sou Accepted
Feb 6, 2024
Divisional Processing Complete
Jan 30, 2024
Divisional Request Received
Feb 6, 2024
Teas/Email Correspondence Entered
Jan 31, 2024
Correspondence Received In Law Office
Jan 31, 2024
Teas Response To Office Action Received
Jan 31, 2024
Teas Response To Office Action Received
Jan 30, 2024
Teas Request To Divide Received
Oct 30, 2023
Application Extension Granted/Receipt Provided
Oct 30, 2023
Application Extension To Response Period - Received
Jul 31, 2023
Notification Of Non-Final Action E-Mailed
Jul 31, 2023
Non-Final Action E-Mailed
Jul 31, 2023
Su - Non-Final Action - Written
Jul 7, 2023
Teas/Email Correspondence Entered
Jul 7, 2023
Correspondence Received In Law Office
Jul 7, 2023
Applicant/Correspondence Changes (Non-Responsive) Entered
Jul 7, 2023
Assigned To Lie
Mar 8, 2023
Teas Response To Office Action Received
Mar 8, 2023
Teas Change Of Correspondence Received
Mar 8, 2023
Teas Withdrawal Of Attorney Received-Firm Retains
Mar 8, 2023
Attorney/Dom.Rep.Revoked And/Or Appointed
Mar 8, 2023
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Sep 8, 2022
Notification Of Non-Final Action E-Mailed
Sep 8, 2022
Non-Final Action E-Mailed
Sep 8, 2022
Su - Non-Final Action - Written
Aug 11, 2022
Notice Of Approval Of Extension Request E-Mailed
Aug 10, 2022
Statement Of Use Processing Complete
Aug 1, 2022
Use Amendment Filed
Aug 10, 2022
Sou Extension 1 Granted
Aug 1, 2022
Sou Extension 1 Filed
Aug 10, 2022
Case Assigned To Intent To Use Paralegal
Aug 1, 2022
Sou Teas Extension Received
Aug 1, 2022
Teas Statement Of Use Received
Feb 1, 2022
Noa E-Mailed - Sou Required From Applicant
Dec 7, 2021
Official Gazette Publication Confirmation E-Mailed
Dec 7, 2021
Published For Opposition
Nov 17, 2021
Notification Of Notice Of Publication E-Mailed
Nov 1, 2021
Approved For Pub - Principal Register
Nov 1, 2021
Examiner's Amendment Entered
Nov 1, 2021
Notification Of Examiners Amendment E-Mailed
Nov 1, 2021
Examiners Amendment E-Mailed
Nov 1, 2021
Examiners Amendment -Written
Oct 29, 2021
Previous Allowance Count Withdrawn
Oct 19, 2021
Withdrawn From Pub - Og Review Query
Oct 7, 2021
Approved For Pub - Principal Register
Oct 1, 2021
Teas/Email Correspondence Entered
Sep 30, 2021
Correspondence Received In Law Office
Sep 30, 2021
Teas Response To Office Action Received
Sep 21, 2021
Notification Of Non-Final Action E-Mailed
Sep 21, 2021
Non-Final Action E-Mailed
Sep 21, 2021
Non-Final Action Written
Sep 11, 2021
Assigned To Examiner
May 21, 2021
New Application Office Supplied Data Entered
Feb 23, 2021
Teas Amendment Entered Before Attorney Assigned
Feb 23, 2021
Teas Voluntary Amendment Received
Feb 20, 2021
New Application Entered
Trademark Alertz updated from USPTO on 2030-01-24
